Company: GANX
Filing Date: 2025-07-17
Form Type: 8-K
Source: 0001104659-25-068530
Chunk: 6

Company: Gain Therapeutics, Inc.
Filing Date: 2025-07-17
Form: 8-K
Item: Item 9.01
Chunk 6
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

  Exhibit No.      Description                                                                                                                
  1.1*             Underwriting Agreement, dated July 16, 2025, by and between Gain Therapeutics, Inc. and Newbridge Securities Corporation.  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  4.1*             Form of Warrant.                                                                                                           
  4.2*             Form of Underwriter’s Warrant.                                                                                             
  4.3*             Form of Warrant Agent Agreement, by and between Gain Therapeutics, Inc. and Pacific Stock Transfer Company.                
  5.1*             Opinion of Lowenstein Sandler LLP.                                                                                         
  23.1*            Consent of Lowenstein Sandler LLP (contained in Exhibit 5.1).                                                              
  99.1**           Launch Press Release, dated July 15, 2025.                                                                                 
  99.2**           Pricing Press Release, dated July 16, 2025.                                                                                
  104              Cover Page Interactive Data File (embedded within the Inline XBRL document).                                               

* Filed Herewith

** Exhibit is being furnished as part of this Current Report on Form
8-K

SIGNATURE

Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                           GAIN THERAPEUTICS, INC.                               
  Date: July 17, 2025      By:                          /s/ Gene Mack            
                           Name:                        Gene Mack                
                           Title:                       Chief Executive Officer